top of page
Revolutionary nanomedicines
to heal ophthalmological disorders
We are a biotechnology start-up company developing novel amphiphilic peptide sequences that self-assemble into nanostructures for sustained delivery of neuropeptides, ions, mRNAs and other biologically active molecules.
Primary open-angle glaucoma as lead indication
Product
bottom of page